| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | gated channel activity | 4.90e-06 | 334 | 76 | 9 | GO:0022836 | |
| GeneOntologyMolecularFunction | transporter activity | KCNMB2 CACNA1B SLC38A2 TRPV1 SLC22A25 KCNH7 TRPM5 ANO6 SLC35B4 TMEM184C ATP11C CACNA1H ABCC12 SERINC5 TMC5 ATP2B3 KCNT1 | 5.31e-06 | 1289 | 76 | 17 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion-gated channel activity | 5.64e-06 | 31 | 76 | 4 | GO:0022839 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.56e-05 | 140 | 76 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | KCNMB2 CACNA1B SLC38A2 TRPV1 SLC22A25 KCNH7 TRPM5 ANO6 SLC35B4 CACNA1H ABCC12 SERINC5 TMC5 ATP2B3 KCNT1 | 3.22e-05 | 1180 | 76 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.77e-05 | 343 | 76 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 6.03e-05 | 459 | 76 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | KCNMB2 CACNA1B SLC38A2 TRPV1 KCNH7 TRPM5 CACNA1H ATP2B3 KCNT1 | 6.67e-05 | 465 | 76 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 6.80e-05 | 182 | 76 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 7.23e-05 | 184 | 76 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 9.40e-05 | 193 | 76 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.05e-04 | 197 | 76 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | alkylglycerophosphoethanolamine phosphodiesterase activity | 1.42e-04 | 5 | 76 | 2 | GO:0047391 | |
| GeneOntologyMolecularFunction | calcium-activated cation channel activity | 1.45e-04 | 27 | 76 | 3 | GO:0005227 | |
| GeneOntologyMolecularFunction | channel activity | 1.67e-04 | 525 | 76 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.69e-04 | 526 | 76 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | KCNMB2 CACNA1B SLC38A2 TRPV1 KCNH7 TRPM5 ANO6 CACNA1H TMC5 ATP2B3 KCNT1 | 1.96e-04 | 793 | 76 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | KCNMB2 CACNA1B SLC38A2 TRPV1 KCNH7 TRPM5 ANO6 CACNA1H ATP2B3 KCNT1 | 2.04e-04 | 664 | 76 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.78e-04 | 151 | 76 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.86e-04 | 152 | 76 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | steroid hormone binding | 2.97e-04 | 7 | 76 | 2 | GO:1990239 | |
| GeneOntologyMolecularFunction | L-serine transmembrane transporter activity | 5.06e-04 | 9 | 76 | 2 | GO:0015194 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | KCNMB2 CACNA1B SLC38A2 TRPV1 KCNH7 TRPM5 ANO6 CACNA1H ATP2B3 KCNT1 | 5.81e-04 | 758 | 76 | 10 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | KCNMB2 CACNA1B SLC38A2 TRPV1 KCNH7 TRPM5 CACNA1H ATP2B3 KCNT1 | 6.12e-04 | 627 | 76 | 9 | GO:0022890 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 7.15e-04 | 46 | 76 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | signal sequence binding | 9.68e-04 | 51 | 76 | 3 | GO:0005048 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.26e-03 | 14 | 76 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | potassium channel activity | 1.45e-03 | 128 | 76 | 4 | GO:0005267 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.49e-03 | 129 | 76 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 2.60e-03 | 20 | 76 | 2 | GO:0061608 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 3.40e-03 | 162 | 76 | 4 | GO:0099106 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 3.79e-03 | 167 | 76 | 4 | GO:0015079 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 4.05e-03 | 25 | 76 | 2 | GO:0031683 | |
| GeneOntologyMolecularFunction | channel regulator activity | 4.39e-03 | 174 | 76 | 4 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 4.66e-03 | 177 | 76 | 4 | GO:0141108 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 4.72e-03 | 27 | 76 | 2 | GO:0008139 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 5.38e-03 | 93 | 76 | 3 | GO:0097110 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | KCNMB2 ADCY10 NLGN3 RELN TRPV1 KCNH7 GPER1 ANO6 GNA11 CACNA1H GNAQ KCNT1 | 7.70e-07 | 559 | 75 | 12 | GO:0042391 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | KCNMB2 CACNA1B SLC38A2 SLC35G1 NLGN3 RELN TRPV1 SLC22A25 KCNH7 TRPM5 GPER1 ANO6 ATP11C CACNA1H GNAQ TMC5 ATP2B3 KCNT1 | 1.49e-06 | 1374 | 75 | 18 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | KCNMB2 CACNA1B SLC38A2 SLC35G1 NLGN3 RELN TRPV1 KCNH7 TRPM5 GPER1 ANO6 ATP11C CACNA1H TMC5 ATP2B3 KCNT1 | 2.00e-06 | 1115 | 75 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | circadian rhythm | 3.30e-05 | 248 | 75 | 7 | GO:0007623 | |
| GeneOntologyBiologicalProcess | metal ion transport | KCNMB2 CACNA1B SLC38A2 SLC35G1 TRPV1 KCNH7 TRPM5 GPER1 ANO6 CACNA1H GNAQ ATP2B3 KCNT1 | 5.84e-05 | 1000 | 75 | 13 | GO:0030001 |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 6.31e-05 | 59 | 75 | 4 | GO:0007215 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 8.80e-05 | 392 | 75 | 8 | GO:0070588 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | KCNMB2 CACNA1B SLC38A2 SLC35G1 TRPV1 KCNH7 TRPM5 GPER1 ANO6 CACNA1H ATP2B3 KCNT1 | 1.15e-04 | 922 | 75 | 12 | GO:0098662 |
| GeneOntologyBiologicalProcess | positive regulation of AMPA receptor activity | 1.30e-04 | 5 | 75 | 2 | GO:2000969 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | KCNMB2 CACNA1B SLC38A2 SLC35G1 TRPV1 KCNH7 TRPM5 GPER1 ANO6 CACNA1H ATP2B3 KCNT1 | 1.41e-04 | 942 | 75 | 12 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | KCNMB2 CACNA1B SLC38A2 SLC35G1 TRPV1 KCNH7 TRPM5 GPER1 ANO6 CACNA1H GNAQ ATP2B3 KCNT1 | 2.50e-04 | 1157 | 75 | 13 | GO:0006812 |
| GeneOntologyBiologicalProcess | regulation of melanocyte differentiation | 2.71e-04 | 7 | 75 | 2 | GO:0045634 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | KCNMB2 CACNA1B SLC38A2 SLC35G1 TRPV1 KCNH7 TRPM5 GPER1 ANO6 CACNA1H ATP2B3 KCNT1 | 2.86e-04 | 1017 | 75 | 12 | GO:0098660 |
| GeneOntologyBiologicalProcess | circulatory system process | KCNMB2 ADCY10 CACNA1B SLC38A2 TRPV1 GPER1 GNA11 CACNA1H GNAQ ATP2B3 | 3.11e-04 | 733 | 75 | 10 | GO:0003013 |
| GeneOntologyBiologicalProcess | regulation of system process | KCNMB2 ADCY10 CACNA1B NLGN3 RELN TRPV1 GPER1 CACNA1H GRM3 ATP2B3 | 3.14e-04 | 734 | 75 | 10 | GO:0044057 |
| GeneOntologyBiologicalProcess | rhythmic process | 3.34e-04 | 360 | 75 | 7 | GO:0048511 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 3.54e-04 | 92 | 75 | 4 | GO:0051966 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating dopamine receptor signaling pathway | 4.62e-04 | 9 | 75 | 2 | GO:0060158 | |
| GeneOntologyBiologicalProcess | regulation of pigment cell differentiation | 4.62e-04 | 9 | 75 | 2 | GO:0050932 | |
| GeneOntologyBiologicalProcess | L-serine transport | 4.62e-04 | 9 | 75 | 2 | GO:0015825 | |
| GeneOntologyBiologicalProcess | potassium ion transport | 4.68e-04 | 272 | 75 | 6 | GO:0006813 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 5.04e-04 | 180 | 75 | 5 | GO:0060078 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 5.15e-04 | 509 | 75 | 8 | GO:0006816 | |
| GeneOntologyBiologicalProcess | blood circulation | 5.58e-04 | 648 | 75 | 9 | GO:0008015 | |
| GeneOntologyCellularComponent | dendrite | ADCY10 CACNA1B SLC38A2 NLGN3 RELN TRPV1 BRINP3 TRPM5 GPER1 DOCK10 CACNA1H GNAQ GRM3 | 1.19e-05 | 858 | 76 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ADCY10 CACNA1B SLC38A2 NLGN3 RELN TRPV1 BRINP3 TRPM5 GPER1 DOCK10 CACNA1H GNAQ GRM3 | 1.22e-05 | 860 | 76 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | synaptic membrane | VANGL2 NLGN3 TRPV1 AP2M1 GPER1 ANO6 CACNA1H GRM3 ATP2B3 KCNT1 | 4.81e-05 | 583 | 76 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | cell body | ADCY10 CACNA1B SLC38A2 NLGN3 RELN TRPV1 BRINP3 TRPM5 GPER1 ACTG2 CACNA1H GNAQ | 1.24e-04 | 929 | 76 | 12 | GO:0044297 |
| GeneOntologyCellularComponent | somatodendritic compartment | ADCY10 CACNA1B SLC38A2 NLGN3 RELN TRPV1 BRINP3 TRPM5 GPER1 DOCK10 CACNA1H GNAQ GRM3 | 4.46e-04 | 1228 | 76 | 13 | GO:0036477 |
| GeneOntologyCellularComponent | postsynaptic membrane | 6.74e-04 | 405 | 76 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | transporter complex | 8.56e-04 | 550 | 76 | 8 | GO:1990351 | |
| GeneOntologyCellularComponent | neuronal cell body | ADCY10 CACNA1B SLC38A2 NLGN3 RELN TRPV1 BRINP3 TRPM5 GPER1 CACNA1H | 8.60e-04 | 835 | 76 | 10 | GO:0043025 |
| MousePheno | abnormal channel response | 1.07e-05 | 33 | 59 | 4 | MP:0003484 | |
| MousePheno | impaired ability to fire action potentials | 1.98e-05 | 13 | 59 | 3 | MP:0002578 | |
| Domain | Gprotein_alpha_Q | 9.50e-05 | 4 | 75 | 2 | IPR000654 | |
| Domain | Ion_trans_dom | 9.53e-05 | 114 | 75 | 5 | IPR005821 | |
| Domain | Ion_trans | 9.53e-05 | 114 | 75 | 5 | PF00520 | |
| Domain | Serpin_fam | 5.12e-04 | 39 | 75 | 3 | IPR000215 | |
| Domain | VDCCAlpha1 | 7.01e-04 | 10 | 75 | 2 | IPR002077 | |
| Domain | RasGAP | 1.62e-03 | 15 | 75 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 1.62e-03 | 15 | 75 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 1.62e-03 | 15 | 75 | 2 | PS50018 | |
| Domain | G-alpha | 1.84e-03 | 16 | 75 | 2 | PF00503 | |
| Domain | GproteinA_insert | 1.84e-03 | 16 | 75 | 2 | IPR011025 | |
| Domain | - | 1.84e-03 | 16 | 75 | 2 | 1.10.506.10 | |
| Domain | - | 1.84e-03 | 16 | 75 | 2 | 1.10.400.10 | |
| Domain | G_alpha | 1.84e-03 | 16 | 75 | 2 | SM00275 | |
| Domain | Gprotein_alpha_su | 2.08e-03 | 17 | 75 | 2 | IPR001019 | |
| Domain | RasGAP_dom | 2.34e-03 | 18 | 75 | 2 | IPR001936 | |
| Pubmed | 3.40e-08 | 85 | 76 | 6 | 23055939 | ||
| Pubmed | GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis. | 4.71e-06 | 2 | 76 | 2 | 27498141 | |
| Pubmed | The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan. | 4.71e-06 | 2 | 76 | 2 | 28248732 | |
| Pubmed | Uveal Melanoma: GNAQ and GNA11 Mutations in a Greek Population. | 4.71e-06 | 2 | 76 | 2 | 28982892 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21083380 | ||
| Pubmed | Activation of Gq/11 in the mouse corpus luteum is required for parturition. | 4.71e-06 | 2 | 76 | 2 | 25495873 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 25304237 | ||
| Pubmed | Epidermal loss of Gαq confers a migratory and differentiation defect in keratinocytes. | 4.71e-06 | 2 | 76 | 2 | 28301547 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16847339 | ||
| Pubmed | Uveal melanoma driver mutations in GNAQ/11 yield numerous changes in melanocyte biology. | 4.71e-06 | 2 | 76 | 2 | 29570931 | |
| Pubmed | Muscarinic inhibition of calcium current and M current in Galpha q-deficient mice. | 4.71e-06 | 2 | 76 | 2 | 10818132 | |
| Pubmed | Endothelial Gαq/11 is required for VEGF-induced vascular permeability and angiogenesis. | 4.71e-06 | 2 | 76 | 2 | 26272756 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 31461351 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23634288 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 26368812 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17482476 | ||
| Pubmed | Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimens. | 4.71e-06 | 2 | 76 | 2 | 21945171 | |
| Pubmed | Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations. | 4.71e-06 | 2 | 76 | 2 | 24141786 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 9175863 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 28083870 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 29289470 | ||
| Pubmed | Stretch regulates alveologenesis and homeostasis via mesenchymal Gαq/11-mediated TGFβ2 activation. | 4.71e-06 | 2 | 76 | 2 | 37102682 | |
| Pubmed | Gq/11-Dependent Changes in the Murine Ovarian Transcriptome at the End of Gestation. | 4.71e-06 | 2 | 76 | 2 | 26843449 | |
| Pubmed | Direct targeting of Gαq and Gα11 oncoproteins in cancer cells. | 4.71e-06 | 2 | 76 | 2 | 30890659 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 7492305 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24308950 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22562663 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11826096 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21366456 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 35580369 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 9607776 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 26192947 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 31726051 | ||
| Pubmed | Papillary Hemangioma Harbors Somatic GNA11 and GNAQ Mutations. | 4.71e-06 | 2 | 76 | 2 | 37750536 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11438569 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 37802294 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 26778290 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 26628681 | ||
| Pubmed | Skeletal Muscle-Specific Activation of Gq Signaling Maintains Glucose Homeostasis. | 4.71e-06 | 2 | 76 | 2 | 30936140 | |
| Pubmed | TRPM5-dependent amiloride- and benzamil-insensitive NaCl chorda tympani taste nerve response. | 4.71e-06 | 2 | 76 | 2 | 23639808 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17552882 | ||
| Pubmed | Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11. | 4.71e-06 | 2 | 76 | 2 | 23778528 | |
| Pubmed | High throughput mass spectrometry-based mutation profiling of primary uveal melanoma. | 4.71e-06 | 2 | 76 | 2 | 22977135 | |
| Pubmed | An experimental strategy to probe Gq contribution to signal transduction in living cells. | 4.71e-06 | 2 | 76 | 2 | 33639168 | |
| Pubmed | GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma. | 4.71e-06 | 2 | 76 | 2 | 32064597 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 23572068 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 31173078 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 25695059 | ||
| Pubmed | Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas. | 4.71e-06 | 2 | 76 | 2 | 29209985 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12351712 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 26476043 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 36440997 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 15713647 | ||
| Pubmed | Distinct roles of Galpha(q) and Galpha11 for Purkinje cell signaling and motor behavior. | 4.71e-06 | 2 | 76 | 2 | 15175381 | |
| Pubmed | GNAQ and GNA11 mutations in melanocytomas of the central nervous system. | 4.71e-06 | 2 | 76 | 2 | 22307269 | |
| Pubmed | Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese. | 4.71e-06 | 2 | 76 | 2 | 25280020 | |
| Pubmed | Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma. | 1.41e-05 | 3 | 76 | 2 | 28700778 | |
| Pubmed | Dissecting Gq/11-Mediated Plasma Membrane Translocation of Sphingosine Kinase-1. | 1.41e-05 | 3 | 76 | 2 | 33003441 | |
| Pubmed | P2Y₂ and Gq/G₁₁ control blood pressure by mediating endothelial mechanotransduction. | 1.41e-05 | 3 | 76 | 2 | 26168216 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 10446129 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 8836152 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 33166186 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 11689889 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 20372981 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 25595485 | ||
| Pubmed | The orphan receptor GPR139 signals via Gq/11 to oppose opioid effects. | 1.41e-05 | 3 | 76 | 2 | 32576659 | |
| Pubmed | Thyrocyte-specific Gq/G11 deficiency impairs thyroid function and prevents goiter development. | 1.41e-05 | 3 | 76 | 2 | 17694176 | |
| Pubmed | Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi. | 1.41e-05 | 3 | 76 | 2 | 23599145 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 15340067 | ||
| Pubmed | Galphao2 regulates vesicular glutamate transporter activity by changing its chloride dependence. | 1.41e-05 | 3 | 76 | 2 | 15872115 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 22758774 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 21464134 | ||
| Pubmed | G protein diversity: a distinct class of alpha subunits is present in vertebrates and invertebrates. | 1.41e-05 | 3 | 76 | 2 | 2123549 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 30552676 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 31580399 | ||
| Pubmed | G alpha(q) signal in osteoblasts is inhibitory to the osteoanabolic action of parathyroid hormone. | 1.41e-05 | 3 | 76 | 2 | 21345793 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 10629036 | ||
| Pubmed | Sensory attributes of complex tasting divalent salts are mediated by TRPM5 and TRPV1 channels. | 1.41e-05 | 3 | 76 | 2 | 19244541 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 34353899 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 16988000 | ||
| Pubmed | Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma. | 1.41e-05 | 3 | 76 | 2 | 28444874 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 9481484 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 31189994 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 12670961 | ||
| Pubmed | GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers. | 1.41e-05 | 3 | 76 | 2 | 30204251 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 30783010 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 31091422 | ||
| Pubmed | G(q/11)α and G(s)α mediate distinct physiological responses to central melanocortins. | 1.41e-05 | 3 | 76 | 2 | 26595811 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 18991294 | ||
| Pubmed | Tamoxifen-inducible Cre-mediated recombination in adipocytes. | 1.41e-05 | 3 | 76 | 2 | 20715175 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 17535809 | ||
| Pubmed | 2.07e-05 | 529 | 76 | 8 | 14621295 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 23696743 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 38643253 | ||
| Pubmed | Galpha12/13 is essential for directed cell migration and localized Rho-Dia1 function. | 2.82e-05 | 4 | 76 | 2 | 16251183 | |
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 38254206 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 9765251 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 27348266 | ||
| Pubmed | 2.82e-05 | 4 | 76 | 2 | 20440069 | ||
| Pubmed | TRPV1 Nociceptor Activity Initiates USP5/T-type Channel-Mediated Plasticity. | 2.82e-05 | 4 | 76 | 2 | 27974205 | |
| Interaction | GRM4 interactions | 7.37e-06 | 11 | 73 | 3 | int:GRM4 | |
| Interaction | ADRA1B interactions | 2.01e-05 | 15 | 73 | 3 | int:ADRA1B | |
| Interaction | TNFRSF10C interactions | 3.61e-05 | 103 | 73 | 5 | int:TNFRSF10C | |
| Interaction | RHOC interactions | VANGL2 SLC38A2 AP2M1 RASA1 ANO6 VPS45 MFSD6 UTP20 GNA11 MPP7 | 4.65e-05 | 584 | 73 | 10 | int:RHOC |
| Interaction | LRRC4 interactions | 4.97e-05 | 20 | 73 | 3 | int:LRRC4 | |
| Interaction | S1PR1 interactions | 5.39e-05 | 112 | 73 | 5 | int:S1PR1 | |
| Interaction | C3orf18 interactions | 6.11e-05 | 115 | 73 | 5 | int:C3orf18 | |
| Interaction | LAMP2 interactions | VANGL2 PIKFYVE SLC38A2 AP2M1 TEX2 ANO6 VPS45 VPS13C TMEM184C ATP11C | 6.60e-05 | 609 | 73 | 10 | int:LAMP2 |
| Interaction | DOCK9 interactions | 7.07e-05 | 61 | 73 | 4 | int:DOCK9 | |
| Interaction | POPDC2 interactions | 7.67e-05 | 23 | 73 | 3 | int:POPDC2 | |
| Interaction | RHOJ interactions | VANGL2 SLC38A2 AP2M1 VPS45 VPS13C MFSD6 DOCK10 UTP20 GNA11 MPP7 | 9.10e-05 | 633 | 73 | 10 | int:RHOJ |
| Cytoband | 10q21.2 | 9.66e-05 | 9 | 76 | 2 | 10q21.2 | |
| GeneFamily | Armadillo repeat containing|Importins | 1.16e-03 | 18 | 51 | 2 | 596 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.43e-03 | 26 | 51 | 2 | 253 | |
| GeneFamily | Transient receptor potential cation channels | 2.81e-03 | 28 | 51 | 2 | 249 | |
| GeneFamily | Serpin peptidase inhibitors | 4.88e-03 | 37 | 51 | 2 | 739 | |
| Coexpression | MIKKELSEN_MEF_ICP_WITH_H3K27ME3 | 2.39e-06 | 207 | 76 | 7 | M1963 | |
| Coexpression | MIKKELSEN_MEF_ICP_WITH_H3K27ME3 | 3.90e-06 | 223 | 76 | 7 | MM838 | |
| Coexpression | GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_UP | 1.76e-05 | 187 | 76 | 6 | M6809 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 3.44e-05 | 429 | 76 | 8 | M29 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 4.80e-05 | 136 | 76 | 5 | M2005 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 6.73e-05 | 146 | 76 | 5 | MM856 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.14e-06 | 198 | 76 | 6 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 1.14e-06 | 198 | 76 | 6 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-06 | 157 | 76 | 5 | a426c54fd1545093d41426e9620862f71bd06f6b | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.55e-06 | 162 | 76 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-05 | 170 | 76 | 5 | 6a98f47f8c2b5b15e09169bd82eff1e6bf76e5a6 | |
| ToppCell | Pericytes-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.24e-05 | 175 | 76 | 5 | ddf721023a7afc8085c5de17aa254a6575444c0f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 178 | 76 | 5 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 1.39e-05 | 179 | 76 | 5 | 83506e00fe99b6450efd2f13f716926a0a4b03cd | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.62e-05 | 185 | 76 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.67e-05 | 186 | 76 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.89e-05 | 191 | 76 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.94e-05 | 192 | 76 | 5 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 1.94e-05 | 192 | 76 | 5 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-05 | 194 | 76 | 5 | 3cd90d01ed5a5ce65aad8284dab2537ec16e3d7c | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.04e-05 | 194 | 76 | 5 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.09e-05 | 195 | 76 | 5 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.14e-05 | 196 | 76 | 5 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.36e-05 | 200 | 76 | 5 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-CHRNA4-L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | e2ced6eb1de9a526c34c7558b9c637854916e624 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | 53d5e427f0cbf5cf0b63efe4ec01da302f555704 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-CHRNA4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.36e-05 | 200 | 76 | 5 | 9bc924755e5a4c464408e6103b86bf1b4e8c58b5 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.36e-05 | 200 | 76 | 5 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.95e-05 | 141 | 76 | 4 | 091b5b72811db5fca2314f4a79d467566920e257 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.58e-04 | 159 | 76 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 162 | 76 | 4 | 164ee1d0543c202831bd349c19e1b36c12f54923 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.70e-04 | 162 | 76 | 4 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 163 | 76 | 4 | 5efecdd8a069a822bc9d35b407092925a865e629 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.74e-04 | 163 | 76 | 4 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 163 | 76 | 4 | 0d94a427f86e62aba12c397c6d7b8cd297f3a0e5 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-04 | 164 | 76 | 4 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-04 | 164 | 76 | 4 | f6a961fa2002da7d9679f32af99e1314c0593ef9 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.78e-04 | 164 | 76 | 4 | b92e7c91910d518627376166c6ea9ed333b3d07e | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.78e-04 | 164 | 76 | 4 | a1e43c6b3e2553f5604100db6e92bf244b70c36d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-04 | 167 | 76 | 4 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.91e-04 | 167 | 76 | 4 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-04 | 168 | 76 | 4 | 4e1b522c7400c9d87f63c00e4e1dd07136095cd6 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-04 | 169 | 76 | 4 | a54a8494c1feff29d77ab4737fcfabc84ace5c94 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_HSPB3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-04 | 170 | 76 | 4 | 985c6c9e3c593ed0628a481f06c2c91b2ab5d746 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Neurod2-Excitatory_Neuron.Slc17a7.Neurod2-Rorb_(Nucleus_of_the_lateral_olfactory_tract_(LOT))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.15e-04 | 68 | 76 | 3 | 6945089858778301a05ecc5895310d768768758c | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Neurod2-Excitatory_Neuron.Slc17a7.Neurod2-Rorb_(Nucleus_of_the_lateral_olfactory_tract_(LOT))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.15e-04 | 68 | 76 | 3 | ac9d0f473c878b96a422bbdd7088eb8125574dde | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.18e-04 | 173 | 76 | 4 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 175 | 76 | 4 | bb058e714d21a0ec8532eaf3c7dd2faf78016bc0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.43e-04 | 178 | 76 | 4 | a48739a588f361b4bc69405d7e256c11f61cf43c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.43e-04 | 178 | 76 | 4 | 0e1bedf991189d0ef9b40dac9281bdf4739333a1 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-04 | 179 | 76 | 4 | dfd5b25f2a6a5a8bf4714f1516cb0997de72b06f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.54e-04 | 180 | 76 | 4 | 8923a42a6db9c6e9f3ce2ca9530e620dfea700ba | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-04 | 180 | 76 | 4 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.54e-04 | 180 | 76 | 4 | 392bc71a69653ba12de31bed4e9357f181094641 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 2.59e-04 | 181 | 76 | 4 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 181 | 76 | 4 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.65e-04 | 182 | 76 | 4 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Hippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.65e-04 | 182 | 76 | 4 | b54ae650c04dfd0759c5f5e752b9bf684dd36516 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.65e-04 | 182 | 76 | 4 | 9966f42c338cbd471efa8ffc765a6ce93693aa75 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.76e-04 | 184 | 76 | 4 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 2.76e-04 | 184 | 76 | 4 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-04 | 185 | 76 | 4 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.82e-04 | 185 | 76 | 4 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.88e-04 | 186 | 76 | 4 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.88e-04 | 186 | 76 | 4 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 2.94e-04 | 187 | 76 | 4 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.94e-04 | 187 | 76 | 4 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.00e-04 | 188 | 76 | 4 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 3.06e-04 | 189 | 76 | 4 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.06e-04 | 189 | 76 | 4 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.06e-04 | 189 | 76 | 4 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.10e-04 | 77 | 76 | 3 | a799ccdb84014e978d9fbccf3d2fee8fbeac7b0c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 190 | 76 | 4 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 190 | 76 | 4 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-04 | 191 | 76 | 4 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.18e-04 | 191 | 76 | 4 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.18e-04 | 191 | 76 | 4 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.18e-04 | 191 | 76 | 4 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.22e-04 | 78 | 76 | 3 | 1ddbb2247450a8b1c159f524dee15bf688748955 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr-Polydendrocyte.Tnr.Ctps_(Ctps)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.22e-04 | 78 | 76 | 3 | 2b0973122052bb26153f066e7b87c26f8a319698 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.24e-04 | 192 | 76 | 4 | 09cb5b89a164ac7444774ccc8c90323c8ea2026b | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.24e-04 | 192 | 76 | 4 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.31e-04 | 193 | 76 | 4 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.31e-04 | 193 | 76 | 4 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.44e-04 | 195 | 76 | 4 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 3.44e-04 | 195 | 76 | 4 | e91ce548ae7224661ee5d2f2639794a5f69798ee | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.44e-04 | 195 | 76 | 4 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.44e-04 | 195 | 76 | 4 | db4270c135c392ed443670981656e3cd5b95939d | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 3.44e-04 | 195 | 76 | 4 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.44e-04 | 195 | 76 | 4 | 6365e3893e38231090ec2dbef010dec71dea3d07 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 3.64e-04 | 198 | 76 | 4 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.64e-04 | 198 | 76 | 4 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 3.64e-04 | 198 | 76 | 4 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.71e-04 | 199 | 76 | 4 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 3.71e-04 | 199 | 76 | 4 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.71e-04 | 199 | 76 | 4 | 64b19aff72e2a109cb5857cb248bd4712dd49b43 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.71e-04 | 199 | 76 | 4 | 60919c2af31d39a2d36d7bc432e43dab2a4e05fb | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-MUC5B+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.71e-04 | 199 | 76 | 4 | 4ab45996e6bca406c77895a5998982b8ab1cf210 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.71e-04 | 199 | 76 | 4 | 2b9e1e069b36b3a61cc3e384f4523687b0e03905 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.71e-04 | 199 | 76 | 4 | 6aca164bbbb961f34b1e6f1857f91ade5c059405 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.79e-04 | 200 | 76 | 4 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-BAGE2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-04 | 200 | 76 | 4 | 26f07d271e984f375145e4c10528fba44a5811e1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-BAGE2-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-04 | 200 | 76 | 4 | c3637827ceba16b0d7956c280dd2ddbc8b1ba55e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-04 | 200 | 76 | 4 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.79e-04 | 200 | 76 | 4 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.79e-04 | 200 | 76 | 4 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| Disease | Sturge-Weber Syndrome | 6.55e-06 | 2 | 76 | 2 | C0038505 | |
| Disease | Phakomatosis cesioflammea | 6.55e-06 | 2 | 76 | 2 | C3838883 | |
| Disease | Port-Wine Stain | 6.55e-06 | 2 | 76 | 2 | C0235752 | |
| Disease | Congenital hemangioma | 6.55e-06 | 2 | 76 | 2 | C0235753 | |
| Disease | Port-wine stain with oculocutaneous melanosis | 6.55e-06 | 2 | 76 | 2 | C1274879 | |
| Disease | Malignant melanoma of iris | 6.51e-05 | 5 | 76 | 2 | C0346373 | |
| Disease | Malignant melanoma of choroid | 6.51e-05 | 5 | 76 | 2 | C0346388 | |
| Disease | alpha-1-antichymotrypsin complex measurement | 1.36e-04 | 7 | 76 | 2 | EFO_0008018 | |
| Disease | Uveal melanoma | 1.81e-04 | 8 | 76 | 2 | C0220633 | |
| Disease | Generalized hypotonia | 6.73e-04 | 15 | 76 | 2 | C1858120 | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 1.60e-03 | 23 | 76 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 1.60e-03 | 23 | 76 | 2 | C0393682 | |
| Disease | Uncinate Epilepsy | 1.60e-03 | 23 | 76 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 1.60e-03 | 23 | 76 | 2 | C0014556 | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 2.37e-03 | 216 | 76 | 4 | EFO_0007925, EFO_0007927 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TYLVIINNMSQLFAM | 211 | Q9NVA4 | |
| AQAIFASMARAMQKY | 391 | Q9ULK5 | |
| LVYNVLKAFMEMNST | 406 | Q16537 | |
| MKINNIQVFGYSMHF | 661 | Q76B58 | |
| MDFSIIQYSKFMTLL | 1 | Q8IVU9 | |
| IQYSKFMTLLAMSLQ | 6 | Q8IVU9 | |
| SQTMMVLVNYIFFKA | 201 | P01011 | |
| MVSLRVMDVQYNKFT | 1071 | P33076 | |
| AMIKSFMDVYQLAST | 1201 | Q6TFL3 | |
| QESKIMFVVNAVYAM | 386 | Q14832 | |
| MMLNIDVSATAFYKA | 211 | Q9UL18 | |
| TQIMFETFNVPAMYV | 121 | P63267 | |
| FMYTMKKFLISNSSQ | 496 | Q96PN6 | |
| HQTFYTIQMFMANVL | 551 | Q96PN6 | |
| IALNTVVLMMKFYDA | 1481 | Q00975 | |
| SEHYTIIFNTFVMMQ | 966 | Q16720 | |
| TLMEQYMKATATQFV | 796 | P20936 | |
| TKLVYQNIFTAMQAM | 76 | P50148 | |
| YENSLTMKMFLFQFV | 546 | Q4KMQ2 | |
| IDVMNGMFLNYRKIF | 146 | Q5JQF8 | |
| MSLVNVVMENFRKYQ | 156 | Q9Y691 | |
| QVLEVKMQVEYMSFS | 376 | Q5TA45 | |
| VAMMFIINFEYVTDN | 121 | Q9NS40 | |
| YSQLITLVNFMKSVM | 411 | Q14C86 | |
| YMADAKTIVNVQTMF | 876 | Q5JUK3 | |
| MQRMIQQFAAEYTSK | 1 | Q96JN0 | |
| QASMMFQYFVKVVPT | 271 | Q9Y282 | |
| FQEMIKSAQIMESQY | 521 | Q5T2T1 | |
| IFFVMLAMQLTYFQR | 911 | Q9UL01 | |
| QNVNAAMVFEFLYKM | 71 | Q96CW1 | |
| VTFVYALYQIKEMMQ | 696 | Q6ZSS7 | |
| VLVSTRKQNYMMNFS | 3426 | P78509 | |
| FSKNDVMLSAVVMTY | 546 | Q9NZ94 | |
| VMENLFYGRKMAQVF | 1936 | Q9Y2I7 | |
| YVFKMVNNYISMFSS | 1071 | Q96BY6 | |
| QNSLMKRVFDTYMLF | 1511 | Q96BY6 | |
| VKLFAANYMMNVIEV | 366 | Q8TDB6 | |
| TKLVYQNIFTAMQAM | 76 | P29992 | |
| AFFSEKILQVYEMMI | 1586 | Q8WXX0 | |
| MVTTYQMAVLLAFNN | 576 | Q13617 | |
| YMAMIQFAINSTERK | 241 | Q08050 | |
| TAIYMMKNFLSQVLQ | 431 | Q86Z14 | |
| SNYIFTAIFVAEMMV | 1331 | O95180 | |
| MVFLIMFNVIVYHQT | 21 | Q6T423 | |
| SMAMQKIYQTFVALA | 386 | Q9BVL2 | |
| NMQMISFAKDTVLTY | 316 | Q9GZK3 | |
| NYKDALSVVFEVMMQ | 156 | Q92552 | |
| SEVMFAMKQFEQLFL | 406 | O75691 | |
| YAIMVTMFFTVSVVN | 66 | Q969S0 | |
| MTYFKVINQMLVFFA | 276 | Q6ZUK4 | |
| FSAMKANTMSNYTLL | 246 | O00204 | |
| FFIMAAMLSMVKYNS | 201 | Q9UKY4 | |
| KEMTQNIYQMATFGT | 66 | Q8IUX1 | |
| YTSQFVSLVMFALMM | 496 | Q06210 | |
| TFMSLFLQVNMYSSV | 131 | Q99527 | |
| TVEMMYQIGTFKLAF | 211 | Q96P15 | |
| VAFSVIAMFNVMKFS | 376 | Q96J65 | |
| FMEMNNFIELFSQKI | 186 | Q9UNH6 | |
| MANVFIYFIMEVSKS | 16 | Q9NY97 | |
| MQLFFYELQMAVKAL | 676 | Q8N957 | |
| SMYVTVEMQKFLGSF | 361 | Q8NB49 | |
| LKQQRMYFVFAQMLS | 1051 | Q8NB49 | |
| IHAAFIFVMTMYTQL | 156 | Q9H6R6 | |
| MNLLIAMFSYTFQVV | 971 | Q9NZQ8 | |
| DNTKFVTSMYNEILM | 301 | Q8NER1 | |
| MQNIGAMSSYLFIVK | 156 | Q96QD8 | |
| NVSKISFFAMFLMYL | 326 | Q96QD8 | |
| TLVQKTLAQAMMYTQ | 611 | O14787 | |
| VFFLASLYVMMTVTN | 396 | Q86VE9 | |
| MNKIMSYSSDFRQIF | 321 | Q8IWV7 | |
| MNVVFAVKQYISKMI | 1 | Q9NRW7 | |
| LQFKYFMVLIQEMAL | 3256 | Q709C8 | |
| NKIAMFQTYAEVTMI | 261 | Q86WI1 | |
| YFAAQTMKMKIQTSF | 61 | Q9Y5L0 | |
| IMKTMDVVFAFIFQI | 316 | Q2M3R5 | |
| QMIMLFIMFYSKNIS | 801 | Q6UXY8 | |
| FTIMAVDMYLIFEQK | 21 | Q8N7C4 | |
| FQKVFVMPNMDDVYI | 1086 | Q8IWB9 | |
| TLFFTNQLRKAVYMM | 231 | Q93009 | |
| ALQYMNFMNVIFAAQ | 171 | Q13889 | |
| FENMKDQIYFMQTET | 316 | P20929 |